Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Helius Medical Technologies Inc HSDT

Healthcare Medical Devices
Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing... see more

Recent & Breaking News (NDAQ:HSDT)

Helius Medical Technologies Announces Positive Results from its Registrational Clinical Trial for Traumatic Brain Injury (TBI)

GlobeNewswire November 9, 2017

Helius Medical Technologies to Report Results from Traumatic Brain Injury Clinical Trials

GlobeNewswire November 8, 2017

Helius Medical Technologies to Present at the Canaccord Genuity Medical Technologies and Diagnostics Conference on November 9, 2017

GlobeNewswire November 1, 2017

Helius Medical Technologies Highlights Publication of Stroke Study From The Royal Melbourne Hospital in Australia Using Investigational PoNS™ Device

GlobeNewswire October 2, 2017

Helius Medical Technologies Appoints Dane C. Andreeff to Board of Directors

GlobeNewswire September 14, 2017

Helius Medical Technologies Announces Extension of Collaborative Research and Development Agreement (CRADA) with US Army

GlobeNewswire September 13, 2017

Helius Medical Technologies Celebrates Grand Opening Ribbon Cutting Ceremony of New Corporate Facility in Newtown, PA

GlobeNewswire August 14, 2017

Helius Medical Technologies Announces Newly Constituted Scientific Advisory Board

GlobeNewswire July 31, 2017

Helius Medical Technologies and the United States Army Medical Research and Materiel Command Announce Last Subject Enrolled In TBI Registrational Clinical Trial

GlobeNewswire July 13, 2017

Helius Medical Announces Closing of CAD$7.0 Million Private Placement

GlobeNewswire June 28, 2017

Helius Medical Announces Research Conducted at the Tactile Communication and Neurorehabilitation Laboratory (TCNL) Using PoNS™ Therapy

GlobeNewswire June 28, 2017

Helius Medical Technologies Receives First of Two Human Performance Patents

Marketwired May 23, 2017

Helius Medical Technologies Receives Two Medical Method Patents

MarketWire Canada April 17, 2017

Helius Medical Technologies Signs 5-Year Lease for Corporate Headquarters in Newtown, PA

Business Wire April 10, 2017

Advocates Reveal State of Progress, Need for More Clinical Research During Brain Injury Awareness Month

Business Wire March 1, 2017

Helius Medical Technologies Inc. Announces Upcoming Participation and Presentation at the Cowen and Company 37th Annual Healthcare Conference

MarketWire Canada February 22, 2017

Helius Medical Technologies, Inc. Closes C$12.5 Million Public Offering of Class A Common Stock, Including Full Exercise of Over-Allotment Option

Business Wire February 16, 2017

Helius Medical Technologies Inc. Closes C$12.5 Million Public Offering of Class A Common Stock, Including Full Exercise of Over-Allotment Option

MarketWire Canada February 16, 2017

Helius Medical Technologies Announces Publication of Multiple Sclerosis Pilot Study Results in Multiple Sclerosis Journal: Experimental, Translational and Clinical

MarketWire Canada February 9, 2017

Helius Medical Technologies Inc. Announces CAD$10.8 Million Public Offering of Class A Common Stock

Canada NewsWire February 9, 2017